Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

11 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
No Evidence That Azathioprine Increases Risk of Cholangiocarcinoma in Patients With Primary Sclerosing Cholangitis.
Zenouzi R, Weismüller TJ, Jørgensen KK, Bubenheim M, Lenzen H, Hübener P, Schulze K, Weiler-Normann C, Sebode M, Ehlken H, Pannicke N, Hartl J, Peiseler M, Hübener S, Karlsen TH, Boberg KM, Manns MP, Lohse AW, Schramm C. Zenouzi R, et al. Among authors: hubener s. Clin Gastroenterol Hepatol. 2016 Dec;14(12):1806-1812. doi: 10.1016/j.cgh.2016.07.032. Epub 2016 Aug 10. Clin Gastroenterol Hepatol. 2016. PMID: 27521513
WITHDRAWN: Reply.
Hübener S, Lohse AW, Schramm C, Than NN, Oo YH. Hübener S, et al. Clin Gastroenterol Hepatol. 2016 Mar 10:S1542-3565(16)00265-2. doi: 10.1016/j.cgh.2016.03.013. Online ahead of print. Clin Gastroenterol Hepatol. 2016. PMID: 26972982
Reply.
Hübener S, Than NN, Oo YH, Lohse AW, Schramm C. Hübener S, et al. Clin Gastroenterol Hepatol. 2016 Jul;14(7):1063-4. doi: 10.1016/j.cgh.2016.04.015. Epub 2016 Apr 16. Clin Gastroenterol Hepatol. 2016. PMID: 27094582 No abstract available.
A prospective pilot study of a gluten-free diet for primary sclerosing cholangitis and associated colitis.
Liwinski T, Hübener S, Henze L, Hübener P, Heinemann M, Tetzlaff M, Hiller MI, Jagemann B, Surabattula R, Leeming D, Karsdal M, Monguzzi E, Schachschal G, Rösch T, Bang C, Franke A, Lohse AW, Schuppan D, Schramm C. Liwinski T, et al. Among authors: hubener s. Aliment Pharmacol Ther. 2023 Jan;57(2):224-236. doi: 10.1111/apt.17256. Epub 2022 Oct 20. Aliment Pharmacol Ther. 2023. PMID: 36266939
A Randomized Trial of a Transglutaminase 2 Inhibitor for Celiac Disease.
Schuppan D, Mäki M, Lundin KEA, Isola J, Friesing-Sosnik T, Taavela J, Popp A, Koskenpato J, Langhorst J, Hovde Ø, Lähdeaho ML, Fusco S, Schumann M, Török HP, Kupcinskas J, Zopf Y, Lohse AW, Scheinin M, Kull K, Biedermann L, Byrnes V, Stallmach A, Jahnsen J, Zeitz J, Mohrbacher R, Greinwald R; CEC-3 Trial Group. Schuppan D, et al. N Engl J Med. 2021 Jul 1;385(1):35-45. doi: 10.1056/NEJMoa2032441. N Engl J Med. 2021. PMID: 34192430 Free article. Clinical Trial.
Chemical characterization of bohrium (element 107).
Eichler R, Bruchle W, Dressler R, Dullmann CE, Eichler B, Gaggeler HW, Gregorich KE, Hoffman DC, Hubener S, Jost DT, Kirbach UW, Laue CA, Lavanchy VM, Nitsche H, Patin JB, Piguet D, Schadel M, Shaughnessy DA, Strellis DA, Taut S, Tobler L, Tsyganov YS, Turler A, Vahle A, Wilk PA, Yakushev AB. Eichler R, et al. Among authors: hubener s. Nature. 2000 Sep 7;407(6800):63-5. doi: 10.1038/35024044. Nature. 2000. PMID: 10993071
11 results